Furthermore, cases had a statistically significantly longer duration of follow up since IBD diagnosis (p < 0.001), but used less thiopurines (p = 0.047) and anti-TNFα agents (p = 0.006) during follow up. This evidence concerns the gene TNF and inflammatory bowel disease.